Clinical Trial Update: Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating myeloablative cord blood transplantation for leukemia and lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Snippet

Sponsor: University College, London | Conditions: Leukaemia, Lymphoma | Phase 2 | Status: TERMINATED